Rockwell Medical Stock Analysis
RMTI Stock | USD 2.29 0.07 3.15% |
Rockwell Medical is undervalued with Real Value of 3.71 and Target Price of 8.0. The main objective of Rockwell Medical stock analysis is to determine its intrinsic value, which is an estimate of what Rockwell Medical is worth, separate from its market price. There are two main types of Rockwell Medical's stock analysis: fundamental analysis and technical analysis.
The Rockwell Medical stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Rockwell Medical's ongoing operational relationships across important fundamental and technical indicators.
Rockwell |
Rockwell Stock Analysis Notes
About 12.0% of the company outstanding shares are owned by corporate insiders. The book value of Rockwell Medical was at this time reported as 0.73. The company recorded a loss per share of 0.04. Rockwell Medical had not issued any dividends in recent years. The entity had 1:11 split on the 13th of May 2022. Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan. Rockwell Medical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 300 people. To find out more about Rockwell Medical contact Mark Strobeck at 248 960 9009 or learn more at https://www.rockwellmed.com.Rockwell Medical Quarterly Total Revenue |
|
Rockwell Medical Investment Alerts
Rockwell Medical generated a negative expected return over the last 90 days | |
Rockwell Medical has high historical volatility and very poor performance | |
Rockwell Medical has a very high chance of going through financial distress in the upcoming years | |
The company reported the previous year's revenue of 83.61 M. Net Loss for the year was (8.44 M) with profit before overhead, payroll, taxes, and interest of 4.08 M. | |
Rockwell Medical currently holds about 27.56 M in cash with (9.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.37, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
Rockwell Medical has a frail financial position based on the latest SEC disclosures | |
Roughly 12.0% of the company outstanding shares are owned by corporate insiders | |
Latest headline from investing.com: Rockwell Automation CEO Blake Moret sells 7.97 million in stock |
Rockwell Medical Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Rockwell Medical previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
4th of April 2024 Upcoming Quarterly Report | View | |
20th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
4th of April 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Rockwell Largest EPS Surprises
Earnings surprises can significantly impact Rockwell Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2024-05-14 | 2024-03-31 | -0.04 | -0.06 | -0.02 | 50 | ||
2024-03-21 | 2023-12-31 | -0.07 | -0.05 | 0.02 | 28 | ||
2023-11-14 | 2023-09-30 | -0.1 | -0.07 | 0.03 | 30 |
Rockwell Medical Environmental, Social, and Governance (ESG) Scores
Rockwell Medical's ESG score is a quantitative measure that evaluates Rockwell Medical's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Rockwell Medical's operations that may have significant financial implications and affect Rockwell Medical's stock price as well as guide investors towards more socially responsible investments.
Rockwell Stock Institutional Investors
Shares | Bailard Inc | 2024-09-30 | 72.8 K | Northern Trust Corp | 2024-09-30 | 63.4 K | Hillsdale Investment Management Inc. | 2024-09-30 | 60.8 K | Cubist Systematic Strategies, Llc | 2024-09-30 | 57.2 K | Algert Global Llc | 2024-09-30 | 50.9 K | Millennium Management Llc | 2024-06-30 | 47.8 K | Wealthtrust Axiom Llc | 2024-09-30 | 38 K | Baader Bank Inc | 2024-09-30 | 35.8 K | Hightower Advisors, Llc | 2024-06-30 | 32.7 K | Armistice Capital, Llc | 2024-09-30 | 3.6 M | Vanguard Group Inc | 2024-09-30 | 1.2 M |
Rockwell Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 74.01 M.Rockwell Profitablity
The company has Profit Margin (PM) of (0.05) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.02 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.02.Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.21) | (0.22) | |
Return On Capital Employed | (0.19) | (0.20) | |
Return On Assets | (0.16) | (0.17) | |
Return On Equity | (0.40) | (0.42) |
Management Efficiency
Rockwell Medical has return on total asset (ROA) of (0.0425) % which means that it has lost $0.0425 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.289) %, meaning that it created substantial loss on money invested by shareholders. Rockwell Medical's management efficiency ratios could be used to measure how well Rockwell Medical manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.22. The current Return On Capital Employed is estimated to decrease to -0.2. As of now, Rockwell Medical's Total Current Assets are increasing as compared to previous years. The Rockwell Medical's current Intangible Assets is estimated to increase to about 13 M, while Total Assets are projected to decrease to under 37.3 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | 0.91 | 0.87 | |
Tangible Book Value Per Share | 0.41 | 0.39 | |
Enterprise Value Over EBITDA | (10.34) | (10.86) | |
Price Book Value Ratio | 2.07 | 1.97 | |
Enterprise Value Multiple | (10.34) | (10.86) | |
Price Fair Value | 2.07 | 1.97 | |
Enterprise Value | 48.5 M | 88.2 M |
Understanding the operational decisions made by Rockwell Medical management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Operating Margin 0.0199 | Profit Margin (0.05) | Beta 1.503 | Return On Assets (0.04) | Return On Equity (0.29) |
Technical Drivers
As of the 1st of December, Rockwell Medical holds the Coefficient Of Variation of (4,753), variance of 48.29, and Risk Adjusted Performance of (0.01). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Rockwell Medical, as well as the relationship between them.Rockwell Medical Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Rockwell Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Rockwell Medical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Rockwell Medical Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Rockwell Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Rockwell Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Rockwell Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Mark Strobeck over two months ago Disposition of 2163 shares by Mark Strobeck of Rockwell Medical at 3.6852 subject to Rule 16b-3 | ||
Megan Timmins over six months ago Disposition of 3137 shares by Megan Timmins of Rockwell Medical at 1.4 subject to Rule 16b-3 | ||
Skibsted Russell over a year ago Acquisition by Skibsted Russell of 80000 shares of Rockwell Medical subject to Rule 16b-3 | ||
Yocum Richard C over a year ago Acquisition by Yocum Richard C of 100000 shares of Rockwell Medical subject to Rule 16b-3 | ||
Smiley Andrea Heslin over a year ago Acquisition by Smiley Andrea Heslin of 24715 shares of Rockwell Medical subject to Rule 16b-3 |
Rockwell Medical Outstanding Bonds
Rockwell Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Rockwell Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Rockwell bonds can be classified according to their maturity, which is the date when Rockwell Medical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Rockwell Medical Predictive Daily Indicators
Rockwell Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Rockwell Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Rockwell Medical Forecast Models
Rockwell Medical's time-series forecasting models are one of many Rockwell Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Rockwell Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Rockwell Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Rockwell Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Rockwell shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Rockwell Medical. By using and applying Rockwell Stock analysis, traders can create a robust methodology for identifying Rockwell entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (0.10) | (0.11) | |
Operating Profit Margin | (0.08) | (0.08) | |
Net Loss | (0.10) | (0.11) | |
Gross Profit Margin | 0.10 | 0.11 |
Current Rockwell Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Rockwell analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Rockwell analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
8.0 | Buy | 2 | Odds |
Most Rockwell analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Rockwell stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Rockwell Medical, talking to its executives and customers, or listening to Rockwell conference calls.
Rockwell Stock Analysis Indicators
Rockwell Medical stock analysis indicators help investors evaluate how Rockwell Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Rockwell Medical shares will generate the highest return on investment. By understating and applying Rockwell Medical stock analysis, traders can identify Rockwell Medical position entry and exit signals to maximize returns.
Begin Period Cash Flow | 10.1 M | |
Long Term Debt | 8.3 M | |
Common Stock Shares Outstanding | 23.3 M | |
Total Stockholder Equity | 21.3 M | |
Property Plant And Equipment Net | 11 M | |
Cash And Short Term Investments | 10.9 M | |
Cash | 9 M | |
Accounts Payable | 4.5 M | |
Net Debt | 4.5 M | |
50 Day M A | 3.3902 | |
Total Current Liabilities | 16.6 M | |
Other Operating Expenses | 90.3 M | |
Non Current Assets Total | 23.4 M | |
Forward Price Earnings | 59.1716 | |
Non Currrent Assets Other | 705 K | |
Stock Based Compensation | 932 K |
Complementary Tools for Rockwell Stock analysis
When running Rockwell Medical's price analysis, check to measure Rockwell Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rockwell Medical is operating at the current time. Most of Rockwell Medical's value examination focuses on studying past and present price action to predict the probability of Rockwell Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rockwell Medical's price. Additionally, you may evaluate how the addition of Rockwell Medical to your portfolios can decrease your overall portfolio volatility.
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |